retatrutide 2025 trial results Today's TRIUMPH-4 are a clear signal: the next generation of incretin medications will be more powerful than anything we've seen before. is showing nearly 30% body-weight reduction in clinical trials Retatrutide: What It Is &

I recommend them to all of my friends

*Keep out of reach of young children

Learn more: Dont Wait Until Renewal One of the biggest mistakes employers make is waiting until 30 or 60 days before renewal to discuss GLP-1 coverage

Preclinical work also points to applications in reproductive health (e.g., PCOS-related fertility improvements) and oncology, where observational studies link GLP-1 use to lower risks of obesity-related cancers

Its activity in diabetic study populations approaches outcomes observed in individuals with obesity without diabetes, indicating its potential as a next-generation subject of investigation